Portfolio company
Mammoth Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This biotechnology company develops ultracompact CRISPR-based gene editing therapies and diagnostic tools for pharmaceutical partners and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Mammoth
This company develops CRISPR-based molecular diagnostics and gene-editing therapies for pharmaceutical partners and healthcare providers.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Sherlock Biosciences
This company develops molecular diagnostic tests using CRISPR and synthetic biology for healthcare providers and consumers to detect infectious diseases and other health conditions.
Aera Therapeutics
This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.
VedaBio
This company develops CRISPR-based molecular diagnostic instruments and cartridges for healthcare providers, urgent care clinics and diagnostic laboratories to enable rapid testing.
Cassidy Bio
This company develops an AI foundation model to design gene editing therapies and prediction tools for pharmaceutical partners and researchers.
Excision Biotherapeutics
This biotechnology company develops CRISPR-based gene editing therapies designed to cure chronic viral infectious diseases for patients.
Caribou Biosciences
This biopharmaceutical company develops genome-edited allogeneic cell therapies to treat patients with hematologic malignancies and other human diseases.
